The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Final results of the randomized phase II DeLOS-II trial: Induction chemotherapy (IC) followed by radiotherapy (R) vs. cetuximab (E) plus IC and R for functional larynx preservation in resectable laryngeal and hypopharyngeal cancer (LHSCC).
 
Andreas Dietz
Honoraria - AstraZeneca; Merck Serono; Merck Sharp & Dohme
Consulting or Advisory Role - AstraZeneca; Merck Serono; Merck Sharp & Dohme
Research Funding - Roche (Inst)
 
Gunnar Wichmann
No Relationships to Disclose
 
Michael Flentje
No Relationships to Disclose
 
Rudolf Hagen
No Relationships to Disclose
 
Oliver Koelbl
No Relationships to Disclose
 
Frank Schreiber
No Relationships to Disclose
 
Volker Schilling
No Relationships to Disclose
 
Georg Maschmeyer
No Relationships to Disclose
 
Ursula Schroeder
No Relationships to Disclose
 
Christian Sittel
No Relationships to Disclose
 
Thomas Lenarz
No Relationships to Disclose
 
Jens Peter Klussmann
No Relationships to Disclose
 
Orlando Guntinas-Lichius
No Relationships to Disclose
 
Claudia Rudack
No Relationships to Disclose
 
Thomas Foerg
No Relationships to Disclose
 
Martin Westhofen
No Relationships to Disclose
 
Hans Juergen Welkoborsky
No Relationships to Disclose
 
Dirk Esser
No Relationships to Disclose
 
Swantje Held
No Relationships to Disclose
 
Ulrich Keilholz
No Relationships to Disclose